CAIO & Advisory.
Some organizations need counsel. Others need someone to own the AI function outright — set the strategy, carry it to the board, and stand behind the decisions. I hold that seat today at XelaOS and at Immersive Solutions Group, and I take it for other organizations on a fractional and interim basis.
Fractional CAIO
Ongoing executive ownership of the AI function at a fraction of a full-time seat — strategy, oversight, and the board relationship.
Interim CAIO
Full ownership through a defined period: a launch, a regulatory deadline, a transaction, or the search for a permanent hire.
Board Advisory
Briefings, risk appetite work, and the oversight structure a board needs to govern AI without becoming its engineers.
Owning the Decision, Not Just the Recommendation.
An advisor writes a memo. An officer signs. In a CAIO engagement I set the AI strategy against a stated risk appetite, decide what gets built and what gets bought, own model oversight and the traceability of outputs, stand up the internal governance function, and answer for all of it in front of the board.
- AI strategy and risk appetite, set with and carried to the board
- Model oversight, evaluation, and traceability by design
- Build-versus-buy decisions and deployment sequencing
- Standing up the internal governance team and its operating cadence
- Vendor and partner decisions across the model supply chain
- Executive briefings, workshops, and cross-functional leadership
In Practice.
XelaOS.
XelaOS is the AI integration layer for healthcare — an EMR-agnostic system that structures data across records, documents, and workflows for clinics, hospitals, home health, hospice, skilled nursing, surgical, and clinical research environments. As its first Chief AI Officer I own model oversight, the governance frameworks, and the compliance backbone as clinical deployments expand.
The core technology pulls structured clinical data out of unstructured, contradictory sources — a domain where a confident wrong answer is both a patient-safety problem and an audit-defensibility problem. Every generated artifact stays traceable to its source, so clinical, quality, and revenue teams can stand behind what the system produces.
Immersive Solutions Group.
Immersive is a global intelligence company building technology designed to raise human intelligence and deliver it in new ways. As Chief AI & Strategy Officer I help guide the company's AI strategy, governance framework, responsible deployment practices, strategic partnerships, and innovation roadmap as its technology portfolio expands.
Here the two halves of the title are the point: strategy decides what gets built and which partnerships accelerate it, while governance decides what ships and on what evidence. Holding both means the roadmap and the guardrails are drawn by the same hand rather than negotiated after the fact.